The aim of the lecture will be to discuss the methodology of early-phase clinical development of classical and more modern molecularly targeted chemotherapeutic drugs. Elements of phase 1 clinical trials and their most common designs will be presented.
Policlinico “G. B. Rossi”
Piazzale L. A. Scuro, 10
37134 Verona
Partita IVA 01541040232
Codice Fiscale:93009870234
© 2002 - 2025
Verona University
Via dell'Artigliere 8, 37129 Verona |
P. I.V.A. 01541040232 |
C. FISCALE 93009870234